Concepedia
Statistics
Publications
19
Citations
496
H-Index
15
Active since
2008
Affiliations
Amgen (United States)(Current)
Mayo Clinic in Arizona
Janssen (United States)
Janssen Scientific Affairs (United States)
University of Chicago
Sumeet Panjabi is an author at Amgen (United States) specializing in pharmacy, multiple myeloma, and pharmacoeconomics.
Publications per year
2008–2023
Treatment adherence, clinical outcomes, and economics of triple-drug therapy in hypertensive patients
Sumeet Panjabi, Michael J. Lacey, Timothy Bancroft et al. · Journal of the American Society of Hypertension · 2013 · 63 citations
Pharmacy, Pharmacoeconomics, Pharmacotherapy +17
Estimation of minimally important differences and responder definitions for EORTC QLQ‐MY20 scores in multiple myeloma patients
Kate Sully, Andrew Trigg, Nicola Bonner et al. · European Journal Of Haematology · 2019 · 57 citations · Full text
Pharmacy, Oncology, Comparative Effectiveness Research +16
Cost-effectiveness of adding carfilzomib to lenalidomide and dexamethasone in relapsed multiple myeloma from a US perspective
Andrzej Jakubowiak, Marco Campioni, Ágnes Benedict et al. · Journal of Medical Economics · 2016 · 51 citations · Full text
Pharmacy, Oncology, Pharmacoeconomics +17
Cost of peripheral neuropathy in patients receiving treatment for multiple myeloma: a US administrative claims analysis
Xue Song, Kathleen Wilson, Jerry Kagan et al. · Therapeutic Advances in Hematology · 2019 · 34 citations · Full text
Pharmacy, Internal Medicine, Pharmacoeconomics +14
Convenience, satisfaction, health-related quality of life of once-weekly 70 mg/m2 vs. twice-weekly 27 mg/m2 carfilzomib (randomized A.R.R.O.W. study)
Philippe Moreau, Shaji Kumar, Ralph V. Boccia et al. · Leukemia · 2019 · 30 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +17
1–5 of 19